GT200600390A - Ibuprofeno solubilizado - Google Patents

Ibuprofeno solubilizado

Info

Publication number
GT200600390A
GT200600390A GT200600390A GT200600390A GT200600390A GT 200600390 A GT200600390 A GT 200600390A GT 200600390 A GT200600390 A GT 200600390A GT 200600390 A GT200600390 A GT 200600390A GT 200600390 A GT200600390 A GT 200600390A
Authority
GT
Guatemala
Prior art keywords
ibuprofen
granulate
potassium
solubilized ibuprofen
solubilized
Prior art date
Application number
GT200600390A
Other languages
English (en)
Inventor
Peter Gruber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35570762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600390(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2006/060973 external-priority patent/WO2006100281A2/en
Application filed filed Critical
Publication of GT200600390A publication Critical patent/GT200600390A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A PROCESO PARA PRODUCIR UN IBUPROFENO SOLUBILIZADO, CON PREFERENCIA EN FORMA DE GRANULADO, EL PROCESO QUE COMPRENDE LOS PASOS DE: PROPORCIONAR UNA MEZCLA QUE COMPRENDE IBUPROFENO SÓLIDO Y UNA PRIMERA BASE SELECCIONADA DEL GRUPO QUE CONSISTE EN HIDRÓXIDO DE SODIO, HIDRÓXIDO DE POTASIO, CARBONATO DE SODIO, CARBONATO DE POTASIO, GLICINATO DE SODIO, ENTRE OTROS, Y HACER REACCIONAR EL IBUPROFENO Y LA PRIMERA BASE ESENCIALMENTE EN ESTADO ANHIDRO. EL GRANULADO ASÍ OBTENIDO SE DISTINGUE POR SU ELEVADA SOLUBILIDAD Y RÁPIDA DESINTEGRACIÓN Y DISOLUCIÓN EN MEDIO ACUOSO.
GT200600390A 2005-12-23 2006-08-29 Ibuprofeno solubilizado GT200600390A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05028321A EP1800667A1 (en) 2005-12-23 2005-12-23 Rapidly solubilizing ibuprofen granulate
PCT/EP2006/060973 WO2006100281A2 (en) 2005-03-22 2006-03-22 Solubilized ibuprofen

Publications (1)

Publication Number Publication Date
GT200600390A true GT200600390A (es) 2007-05-30

Family

ID=35570762

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600390A GT200600390A (es) 2005-12-23 2006-08-29 Ibuprofeno solubilizado

Country Status (6)

Country Link
EP (1) EP1800667A1 (es)
AR (1) AR056469A1 (es)
CR (1) CR9424A (es)
GT (1) GT200600390A (es)
PE (1) PE20070765A1 (es)
TW (1) TW200738286A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE489077T1 (de) * 2006-09-28 2010-12-15 Losan Pharma Gmbh Schnell lösliche formulierung von nichtsteroidalen antiphlogistika
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629806B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
GB2546513B (en) * 2016-01-20 2020-09-16 Cubic Pharmaceuticals Ltd Process of preparing active pharmaceutical ingredient salts

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197038B (it) 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US4859704A (en) 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
FI89004C (fi) 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
DE3838431A1 (de) 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
DE3922441A1 (de) 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
US5262179A (en) 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
GB9224021D0 (en) 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
ES2134796T3 (es) 1992-12-01 1999-10-16 Spirig Ag Pharmazeutische Prap Composiciones farmaceuticas que contienen s(+)-ibuprofeno.
EP0667149A1 (en) * 1994-02-14 1995-08-16 E-PHARMA TRENTO S.p.A. Ibuprofen based effervescent composition
DE19509807A1 (de) 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE19606151C2 (de) 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
GB9603699D0 (en) 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
FR2785539B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
EP1305008A4 (en) 2001-03-27 2005-02-09 R P Scherer Technologies Inc A Improved forms of pharmaceutical ingredients and method for their preparation
US20020192161A1 (en) 2001-04-10 2002-12-19 Fahkreddin Jamali Animal model for evaluating analgesics
CH693586A8 (de) 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.

Also Published As

Publication number Publication date
CR9424A (es) 2008-01-21
EP1800667A1 (en) 2007-06-27
AR056469A1 (es) 2007-10-10
TW200738286A (en) 2007-10-16
PE20070765A1 (es) 2007-08-10

Similar Documents

Publication Publication Date Title
GT200900060A (es) Procedimiento de preparación de halogenuros de n-alquil-naltrexona
MX2009013255A (es) Matriz de solidificacion que incluye una sal de un acido mono-, di- o tri-carboxilico saturado de cadena recta.
ES2628852T3 (es) Proceso para la producción de bicarbonato de sodio para desulfuración de gases de combustión
AR047984A1 (es) Detergentes solidos para lavar la ropa con tensioactivo de amonio polianionico
ES2564807T3 (es) Proceso para preparación de rosuvastatina de calcio amorfa pura
GT200600390A (es) Ibuprofeno solubilizado
AR074503A1 (es) Composiciones blanqueadoras de capas solidas
AR087730A1 (es) Composiciones detergentes
TW200641536A (en) Positive resist composition and pattern-forming method using the same
CL2009000213A1 (es) Cartucho explosivo que permite desactivar la composición explosiva en caso de que ésta no detone según lo proyectado, que comprende, una composicion explosiva, un agente desactivador de la composicion explosiva, y un elemento de barrera que evita el contacto entre la composición explosiva y el agente desactivador.
GT201000076A (es) Método para producir 2´-desoxi 5-azacitidina (decitabina)
AR090436A1 (es) Particulas detergentes para el lavado de ropa
AR071060A1 (es) Proceso para la preparacion de betainas
JP2011502208A5 (es)
AR108083A1 (es) Composiciones, kits y métodos para mantener la higiene del párpado
ES2534751T3 (es) Procedimiento para el tratamiento de ácido 4-beta-sulfatoetilsulfonilanilin-2-sulfónico
CL2008002275A1 (es) Proceso para producir 3-cloro-n-(3-cloro-5-trifluorometil-2-piridil)-a,a,a-trifluoro-2,6-dinitro-p-toluidina usando un solvente del tipo cetonas, nitrilos, esteres y eteres en presencia de 20 a 40% p/p de agua.
AR081891A1 (es) Proceso para elaborar una composicion detergente liquida
BRPI0509923A (pt) processo para formação de cálcio de atorvastatina amorfa
PE20060740A1 (es) Proceso de fabricacion de derivados de salicilamidas n-sustituidas
PA8644301A1 (es) Composicion farmaceutica
ES2585569T3 (es) Método para disolver dióxido carbono procedente de gas de combustión u otro gas y para neutralizar la disolución obtenida
AR037106A1 (es) Composiciones detergentes, particulado para el lavado de ropa y procedimiento de elaboración.
ATE340821T1 (de) Carboxymethylcellulose mit verbesserter löslichkeit im wasser
AR078608A1 (es) Composiciones de hipoclorito para dentaduras y metodos de uso